Business Description
Woojung Bio Inc
Gwanggyo-ro 145, B-dong 3rd Floor, Next Generation Convergence Technology Research Center, Gyeonggi-do, Yeongtong-gu, Suwon-si, KOR
Compare
Compare
Traded in other countries / regions
215380.Korea
Description
Woojung Bio Inc is engaged in the research and development of natural science and engineering. Its products include Gene Delivery, Antibody Production, Immunodeficiency model, Human-to-human model, Zika, Mers, Dengue, Influenza Virus Research, Influenza virus, vaccine studies, and Elegant Goettingen Mini Pig.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.13 | |||||
| Equity-to-Asset | 0.3 | |||||
| Debt-to-Equity | 1.33 | |||||
| Debt-to-EBITDA | 28.05 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 0.35 | |||||
| Beneish M-Score | -2.44 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.7 | |||||
| 3-Year EPS without NRI Growth Rate | 49.1 | |||||
| 3-Year FCF Growth Rate | -75.4 | |||||
| 3-Year Book Growth Rate | 5.4 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.6 | |||||
| 9-Day RSI | 40.78 | |||||
| 14-Day RSI | 45.15 | |||||
| 6-1 Month Momentum % | -4.03 | |||||
| 12-1 Month Momentum % | -30.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.53 | |||||
| Quick Ratio | 0.41 | |||||
| Cash Ratio | 0.12 | |||||
| Days Inventory | 54.95 | |||||
| Days Sales Outstanding | 55.52 | |||||
| Days Payable | 34.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.3 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 15.01 | |||||
| Operating Margin % | -12.14 | |||||
| Net Margin % | -9.03 | |||||
| ROE % | -11.02 | |||||
| ROA % | -3.44 | |||||
| ROIC % | -4.49 | |||||
| ROC (Joel Greenblatt) % | -3.43 | |||||
| ROCE % | -3.37 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.85 | |||||
| PB Ratio | 2.05 | |||||
| Price-to-Tangible-Book | 2.12 | |||||
| Price-to-Operating-Cash-Flow | 14.24 | |||||
| EV-to-EBIT | -49.9 | |||||
| EV-to-EBITDA | 67.62 | |||||
| EV-to-Revenue | 2.77 | |||||
| EV-to-FCF | -3.32 | |||||
| Earnings Yield (Greenblatt) % | -2 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₩) | 35,409.213 | ||
| EPS (TTM) (₩) | -258 | ||
| Beta | 0.85 | ||
| Volatility % | 23.82 | ||
| 14-Day RSI | 45.15 | ||
| 14-Day ATR (₩) | 195.022797 | ||
| 20-Day SMA (₩) | 5038.25 | ||
| 12-1 Month Momentum % | -30.04 | ||
| 52-Week Range (₩) | 4300 - 8100 | ||
| Shares Outstanding (Mil) | 12.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Woojung Bio Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||